Optimal Care Pathways Steering Committee
Dr Caroline M Bateman, Paediatric Haematologist and Oncologist, Cancer Centre for Children, The Children’s Hospital at Westmead
Julia Brancato, Optimal Care Pathways Project Coordinator, Cancer Council Victoria
Dr Peter Diamond, Project Secretariat, Leukaemia Foundation
Associate Professor Michael Dickinson, Haematologist, Lymphoma Australia, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne
Associate Professor Anoop Enjeti, Haematologist, John Hunter Hospital, Senior Staff Haematologist, Calvary Mater Hospital, Conjoint Associate Professor, University of Newcastle
Emily Forrest, Project Secretariat, Leukaemia Foundation
Fiona Haigh, Project Secretariat, Leukaemia Foundation
Deborah Henderson, Consumer Representative
Professor Tim Hughes, Haematologist, South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, Royal Adelaide Hospital
Professor Steven Lane, Haematologist, Royal Brisbane and Women’s Hospital, QIMR
Berghofer Medical Research Institute, University of Queensland
Caroline Nehill, Director National Cancer Control, Cancer Australia
Professor H. Miles Prince AM, Haematologist, Epworth Healthcare and Haematologist
Peter MacCallum Cancer Centre
Professor Hang Quach, Haematologist, University of Melbourne, St. Vincent’s Hospital Melbourne
Catriona Rafael, Project Secretariat, Leukaemia Foundation
Professor Andrew Roberts AM, Haematologist and Bone Marrow Transplant Physician, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, University of Melbourne, Walter and Eliza Hall Institute
Professor John Seymour AM, Haematologist, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne
Delaine Smith, Chief Executive Officer, Australasian Leukaemia and Lymphoma Group
Professor Judith Trotman, Haematologist, Concord Repatriation General Hospital, University of Sydney
Megan Varlow, Director Cancer Control Policy, Cancer Council Australia
Dr Nicole Wong Doo, Haematologist, Concord Repatriation and General Hospital, University of Sydney
Our thanks also to the Blood Cancer Taskforce, which recommended the development of optimal care pathways for all the major blood cancer subtypes as part of the National Strategic Action Plan for Blood Cancer (2020). The National Action Plan was commissioned by the Federal Government and developed by the Blood Cancer Taskforce, with support from the Leukaemia Foundation.